| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/12/2011 | CN1943781B Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2011 | CN1922157B Benzo[d]isoxazol-3-ol daao inhibitors |
| 01/12/2011 | CN1903239B Method for extraction and separation of rhizome of chuanixong |
| 01/12/2011 | CN1785272B Medicinal composition and its preparation method |
| 01/12/2011 | CN101946001A Polypeptide-nucleic acid conjugates and uses thereof |
| 01/12/2011 | CN101945876A Nitrogen-containing bicyclic compounds active on chronic pain conditions |
| 01/12/2011 | CN101945872A (1-azinone) -substituted pyridoindoles as mch antagonists |
| 01/12/2011 | CN101945868A Gamma secretase modulators |
| 01/12/2011 | CN101945855A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 01/12/2011 | CN101945848A Tetrasubstituted benzenes |
| 01/12/2011 | CN101945663A Bioassay method for yokukansan |
| 01/12/2011 | CN101945655A 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 01/12/2011 | CN101945650A Combination comprising a cannabinoid receptor binding compound and an opioid |
| 01/12/2011 | CN101945648A Pharmaceutical formulation containing choline alfoscerate |
| 01/12/2011 | CN101942481A Construction and application of recombined lentivirus vector aiming at RNA interference of PKC gamma genes |
| 01/12/2011 | CN101942444A Small RNA for human and rat-homologous NMDA receptor NR2B and application thereof |
| 01/12/2011 | CN101942393A Huperzia serrata endophytic fungus shiraia sp. strain for producing huperzine A |
| 01/12/2011 | CN101941948A Histone deacetylase inhibitor with branched structure and synthesized through click chemistry |
| 01/12/2011 | CN101941907A 4-tertiary butyl benzyl-3,4-dyhydroxyl cinanmate as well as application and preparation method thereof |
| 01/12/2011 | CN101940785A Hydrogen sulfide-producing enzyme preparation and use thereof |
| 01/12/2011 | CN101940779A Method for preparing medicinal composition for reinforcing spleen and kidney |
| 01/12/2011 | CN101940775A Chinese medicinal herbs for treating gastrointestinal neurosis |
| 01/12/2011 | CN101940770A Medicament for treating insomnia and preparation method thereof |
| 01/12/2011 | CN101940753A Traditional Chinese medicine preparation for treating viral encephalitis |
| 01/12/2011 | CN101940750A Traditional Chinese medicine for senile dementia and preparation method thereof |
| 01/12/2011 | CN101940729A Chinese medicinal preparation for treating vegetative nerve functional disturbance |
| 01/12/2011 | CN101940727A Chinese medicinal preparation for treating epidemic meningitis |
| 01/12/2011 | CN101940726A Medicament for treating tourette syndrome |
| 01/12/2011 | CN101940710A Health-care wine for regulating sleep and preparation method thereof |
| 01/12/2011 | CN101940703A Tincture having treating and adjusting health-care effects |
| 01/12/2011 | CN101940700A Dai nationality medicine for treating rheumatism |
| 01/12/2011 | CN101940685A Face-beautifying health wine and preparation method thereof |
| 01/12/2011 | CN101940679A Traditional Chinese medicine composition capable of soothing mood and collecting mind |
| 01/12/2011 | CN101940675A Chinese medicinal herb for treating facial neuritis |
| 01/12/2011 | CN101940674A Chinese medicament for treating diabetic peripheral neuropathy |
| 01/12/2011 | CN101940619A Chinese medicinal preparation for treating guillain-barre syndrome (GBS) diseases and preparation method thereof |
| 01/12/2011 | CN101940610A Preparation method of astragalus extractive |
| 01/12/2011 | CN101940603A Medicament for treating epilepsy and preparation method thereof |
| 01/12/2011 | CN101940596A New method for preparing cerebroprotein hydrolysate |
| 01/12/2011 | CN101940589A Medicament for preventing and treating neurologic damage and related diseases thereof |
| 01/12/2011 | CN101940588A Application of benzoylated phaeophyceae polysaccharide for preparing medicines for treating Parkinson disease |
| 01/12/2011 | CN101940584A Use of isoflavone compound |
| 01/12/2011 | CN101940583A Antidepressant application of composition of paeoniflorin and albiflorin and preparation method thereof |
| 01/12/2011 | CN101940570A Composite of ligustrazine phosphate and danshensu and application thereof |
| 01/12/2011 | CN101940561A Quetiapine fumarate tablet and preparation method thereof |
| 01/12/2011 | CN101940558A (-)-Epigallocatechin-3-gallate pill composition and application thereof |
| 01/12/2011 | CN101940419A Novel health-care pillow |
| 01/12/2011 | CN101530579B A pharmaceutical composition for soothing the nerves |
| 01/12/2011 | CN101450041B Nano lycorine chloride microcapsule latex and preparation method thereof |
| 01/12/2011 | CN101416948B Quetiapine fmarate dispersible tablets |
| 01/12/2011 | CN101380433B Combination with antialcoholism action and preparation method thereof |
| 01/12/2011 | CN101337003B Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion and sciatica |
| 01/12/2011 | CN101292971B Use of chicoric acid in preparing medicaments for treating dementia diseases |
| 01/12/2011 | CN101284043B Plaster for treating facial paralysis and preparation method thereof |
| 01/12/2011 | CN101273014B 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 01/12/2011 | CN101262868B Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof |
| 01/12/2011 | CN101259151B Preparation technique for passionflower total flavones and total saponins without alkaloid and cyanogenic glycoside |
| 01/12/2011 | CN101229307B Rehabilitation oral Chinese traditional medicine preparation and preparing process thereof |
| 01/12/2011 | CN101095745B Particles for invigorating the spleen and preparation method |
| 01/12/2011 | CN101076340B GABA-steroid antagonists and their use for the treatment of cns disorders |
| 01/11/2011 | US7868041 prodrugs of gabapentin and pregabalin, such as 2-[1-[[[(2R)-6-oxooxan-2-yl]oxycarbonylamino]methyl]cyclohexyl]aceticacid, used for for treating epilepsy, depression, anxiety, psychosis, brain disorders, neurodegenerative diseases, pain, inflammatory disease, gastrointestinal disorders or drug abuse |
| 01/11/2011 | US7868034 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 01/11/2011 | US7868029 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates |
| 01/11/2011 | US7868028 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants |
| 01/11/2011 | US7868022 Drug for Alzheimer's disease; cognition activators; strokes; down's disease; Parkinson's disease |
| 01/11/2011 | US7868018 such as N [3-(2-(3-trifluoromethyl)-benzoylamino -[1,6]naphthyridin-3-yl)-2,4-dichloro-phenyl]-3-trifluoromethyl-benzamide, used as antiproliferative agents or for the treatment of autoimmune diseases and nervous system disorders |
| 01/11/2011 | US7868005 Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
| 01/11/2011 | US7867509 Fast dissolving orally consumable films |
| 01/11/2011 | CA2518740C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 01/11/2011 | CA2487973C Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol |
| 01/11/2011 | CA2472149C New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments |
| 01/11/2011 | CA2469876C Benzothiazoles |
| 01/11/2011 | CA2460696C Use of substituted aminomethyl chromans for the treatment of extrapyramidal movement disorders |
| 01/11/2011 | CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies |
| 01/11/2011 | CA2453445C Pyridin-2-yl-methlyamine derivatives for treating opioid dependence |
| 01/11/2011 | CA2448242C Use of acetyl l-carnitine for the preparation of a medication for the preventive therapy for pain |
| 01/11/2011 | CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/11/2011 | CA2420592C Fused pyrrolocarbazoles against inflammation |
| 01/11/2011 | CA2404387C Theanine compositions for promoting sleep |
| 01/11/2011 | CA2400486C Aniline-derived ligands for the thyroid receptor |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/11/2011 | CA2374039C Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 01/11/2011 | CA2372063C Pyridopyranoazepine derivatives, their preparation and their therapeutic application |
| 01/11/2011 | CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/11/2011 | CA2286313C Novel ldl-receptor |
| 01/10/2011 | CA2671320A1 .beta.-phenylethylidenehydrazine derivatives |
| 01/06/2011 | WO2011003064A2 Methods of treating neuropathic pain |
| 01/06/2011 | WO2011002984A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands |
| 01/06/2011 | WO2011002910A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/06/2011 | WO2011002409A1 5h-pyrrolo[3,4-£>]pyrazin-7-amine derivatives inhibitors of beta-secretase |
| 01/06/2011 | WO2011002408A1 Novel compounds for treatment of neurodegeneration associated with diseases, such as alzheimer's disease or dementia |
| 01/06/2011 | WO2011002407A1 Novel compounds for treatment of neurodegeneration associated with diseases, such as alzheimer's disease or dementia |
| 01/06/2011 | WO2011002405A1 2-carboxamide-7-piperazinyl-benzofuran derivatives 774 |
| 01/06/2011 | WO2011002168A2 Use of novel lactobacillus helveticus or a culture thereof for preventing or treating dementia or cognitive dysfunction |
| 01/06/2011 | WO2011002067A1 Heterocyclic compound and use thereof |
| 01/06/2011 | WO2011002026A1 Amyloid fibril formation inhibitor and use thereof |
| 01/06/2011 | WO2011001931A1 Novel oxadiazole derivative |
| 01/06/2011 | WO2011001169A1 Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy |